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Summary: A method is presented for the determination of dextran concentrations. Following acid hydrolysis
and partial neutralization, the resulting glucose is determined with the aid of glucose oxidase. Specificity is
better than that of previously applied methods. Mean recovery is 100.2 ± 1.6% (SD) for concentrations from
180 mg · Γ1 to 6000 mg · I"1. Coefficients of variation are 2.2% for 240 mg -1"1, 1.2% for 600 mg · Γ1 and
1.8% for 1200 mg · I"1. When used for volume measurements, the accuracy is 99.3 ± 2.1% (SD) for volumes
of 2.5 to 3 liters.
Introduction
Dextrans are used widely as plasma substitutes and
antithrombotic agents. The fact that they are well
retained intravascularly also makes them suitable for
vascular permeability research and for plasma volume
measurement with a dilution technique. Dextran con-
centrations have been determined in several different
ways: estimation of reducing power according to Ha·^
gedorn-Jensen after acid hydrolysis (1), complex for-
mation with copper (2), serological (3), polarimetric
(4), carbohydrate determination with anthrone and
sulphuric acid (5, 6) and turbidimetrically (7). These
methods are lacking either in sensitivity or in speci-
ficity, which has complicated their use and necessi-
tated many modifications (8 — 13).
In the method described here, dextran is hydrolysed
to glucose by heating with hydrochloric acid accord-
*) Enzymes:
1. Glucose oxidase ( -D-glucose: oxygen oxidoreductase,
EC 1.1.3.4)
2. Hexokinase (ATP: /)-hexose 6-phosphotransferase, EC
2.7.1.1)
3. Peroxidase (donor: hydrogen-peroxide oxidoreductase,
EC 1.11.1.7)
ing to Gohr, Bolte & Langenberg (1); the glucose is
finally determined not chemically through its reducing
power, but enzymatically with the aid of a commercial
kit (GOD-PAP, see below under procedure) contain-
ing glucose oxidase and peroxidase,1) thereby en-
hancing sensitivity and specificity. Glucose oxidase
was previously used in dextran determinations only
to remove glucose from samples before hydrolysis
(11). The dextran preparation used in our experiments
was a 6% dextran 70000 solution in 9g/l NaCl,
containing dextran with a mean relative molecular
mass of 70000 (NPBI, batch Nr. 8610131101).
Procedure
Required reagents
Hydrochloric acid 6 mol/1 (add 300 ml HC1 37% - Merck
cat. No. 317.1000 — to water, and adjust volume to 500
ml)
Sodium hydroxide 262.5 g · Γ1 (dissolve 52.2 g NaOH -
Merck cat. No. 6498.1000 — in water, and adjust volume
to 200 ml)
Glucose oxidase-phenol-aminophenazone reagent (GOD-
PAP - Boehringer Mannheim cat. No. 166391)
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To 1.0 ml of serum were added 0.1 ml of demineralised water
(to fit the calibration line, see below) and 0.5 ml of 6mol/l
hydrochloric acid in 15 ml glass test tubes. Acid was added
while mixing thoroughly on a vortex mixer. Tubes were sealed
with glass marbles and placed in a boiling waterbath for 75
minutes to hydrolyse the dextran. The tubes were then cooled
in cold water for 2 minutes and subsequently centrifuged for
25 minutes at 2100 g (or for 35 minutes at 1300 g). Supernatant
(0.5 ml) was pipetted into 3 ml test tubes and partially neu-
tralized by the addition of 0.150 ml of the sodium hydroxide
solution with thorough mixing.
The remaining part of the determination was done with the aid
of a compact clinical analyzer and the KONE sample processor.
Volumes taken from samples and reagents were adjusted with
the sampling unit. For dextran determinations 0.020 ml of
sample was added to 0.500 ml of the GOD-PAP reagent. For
routine glucose determinations, 0.010 ml of sample was added
to the reagent. The incubation time was 30 minutes at room
temperature. Absorbance was subsequently read at 510 run
with the analysing unit, which also calculated glucose concen-
trations (in the case of glucose determinations) or glucose
equivalents (in the case of dextran determinations) from the
absorbances of simultaneously measured duplicate glucose-free
blanks and glucose standard solutions. The glucose standard
solutions were prepared in our laboratory, using glucose dis-
solved in a 6 g/Γ benzoic acid solution in water, containing 9.0
mmol · I"1 for routine glucose determinations or 4.5 mmol · I"1
for dextran determinations. The setting of the reference con-
centration for the analysing units was left unchanged at 9.0
mmol · I"1 for dextran determinations in order to expand the




Determination of optimal boiling time
Triplicate test tubes containing 1.0 ml of mixed serum,
0.1 ml of a 12000 mg · Γ1 dextran solution prepared
from the 6% solution and 0.5 ml 6 mol/1 HC1 were
placed in a boiling waterbath and removed at 10
minute intervals. One set of tubes was not boiled at
all and served as a blank. For this part of the exper-
iments samples were neither centrifuged nor neutral-
ised with NaOH. Glucose concentrations were deter-
mined as described under Procedure. The glucose
concentration reached a constant level after 60 min-
utes and remained constant till 90 minutes, after which
evaporation effects became noticeable. An optimal
boiling time of 75 min was therefore chosen (fig. 1).
Determination of the optimal amount of neu-
tralisation
The addition of more than 0.010 ml of the unneu-
tralized hydrolysate to the enzyme solution, for the
purpose of increasing sensitivity, caused a decrease in
the recovery of the assay. This negative effect was
overcome by neutralizing the hydrolysate. The re-
quired amount of NaOH was determined as follows:
duplicate test tubes containing 1.0 ml of mixed serum,
0.1 ml of a 12000 mg · I'1 dextran solution and 0.5
ml of 6 mol/1 HC1 were placed in a boiling waterbath
for 75 minutes. After centrifuging, 262.5 g · Γ1 NaOH
solution was added to 0.500 ml of the supernatant,
in volumes between 0.125 ml and 0.225 ml. The pH
of these samples ranged from 0.4 to 13.2 as indicated
in figure 2. Subsequently 0.020 ml· of the samples was
added to 0.500 ml of GOD-PAP reagent in order to
determine glucose equivalents (fig. 2). The optimal
volume of NaOH was found to be 0.150 ml. This
resulted in a pH of 6.55 instead of the normal 7.00













Fig. 1. Optimal boiling time
Glucose concentration measured in samples removed






125 150 175 200 225
ΝαΟΗ [μΐ]
ΟΛ 0.8 8.3 12.8 13,5
pH
Fig. 2. Optimal volume of added NaOH
Dextran value and pH measured in samples with 0.150
to 0.225 ml of 262,5 g -1--1 NaOH added after hydrolysis
(n-2). - '
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Recovery
Recovery was determined by measuring glucose con-
centration in triplicate samples of hydrolysates of
mixed serum containing 180, 240,420, 600,900,1200,
1500, 3000 and 6000 mg dextran per litre and sub-
tracting the glucose concentration of the blanks. Glu-
cose content was calculated from glucose concentra-
tion and total sample volume assuming no fluid had
been lost by evaporation. Mean recovery was 100.2
+ 1.6% (SD). In mixed serum samples containing 60,
90 and 120 mg · I"1 recovery was 73 ± 2.8% (SD)
(tab. 1).
Calibration line
Calibration lines were drawn for mixed serum as well
as for water samples. To 1.0 ml of serum or water
was added 0.1 ml of dextran standard solution con-
taining 600, 900, 1200, 1500, 1800, 2100, 2400, 3000,
3750, 4500, 5250, 6000, 9000, 12000 or 15000
mg · I""1. Standard solutions were prepared by diluting
2, 3, 4, 5, 6, 7, 8, 9, 10, 12.5, 15, 17.5, 20, 30, 40, and
50 ml of the 6% dextran solution with water to 200
ml. Water (0.1 ml) was added to the blank samples.
Triplicate samples were treated as described under
Procedure. The calibration lines were drawn by plot-
ting glucose equivalents against dextran concentration
after subtraction of the blanks. The slope of
/ glucose equivalents \ _ ΛΛ*·^ , , ,^ —— was 0.00527 under the de-\dextran concentration/
scribed conditions for both water and mixed serum
samples (fig. 3).
Duplication
Duplication was determined in mixed serum samples
containing 240 mg · Γ1 (n = 18), 600 mg · I""1







Glucose equivalents determined from standard dextran
solutions in water. The slope is 0.00527.
pies were treated as described under Procedure. The
coefficients of variation were 2.2% for 240 mg -1"1,
1.2% for 600 mg · Γ1 and 1.8% for 1200 mg -1"1.
Reproducibility
On 5 different occasions 0.1 ml of a 6000 mg - I""1
dextran solution was added to 1.0 ml of water, and
the dextran values were determined in duplicate. The
coefficient of variation was 2.1%.
Interfering substances
The following solutions (0.2 ml) were added to mixed
serum (1.0 ml) in order to test their influence on the
dextran value of blanks: Geloplasm, Haemaccel, so-
dium citrate 3.1%, heparin 5000 IE · ml""1, protamine
10g -Γ1, mannitol 20% and sorbitol 40%. Blanks
consisted of 0.2 ml of water and 1.0 ml mixed serum.
The only substance causing an interference was sor-
bitol; at the test concentration of 6.67%, sorbitol
produces an analytical response equivalent to 200
mg -1 ""J of dextran (tab. 2).
Tab. 1. Recovery
Percentage difference for mixed serum samples contain-
ing several concentrations of dextran and glucose.
Mean recovery for concentrations 120—6000 mg -I"1
was 100.2 ± 1.6% (SD). Mean recovery for 60, 90 and
120 mg · Γ1 was 73 ± 2.8% (SD).





































Tab. 2. Interfering substances
Effect on the glucose equivalent of adding 0.200 ml of
various solutions to 1.0 ml of mixed serum (blanks:
0.200 ml water added). Glucose equivalents expressed






Heparin 5000 IE · ml~!
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Volume determination
In order to test the accuracy of the method for volume
determination, 40 ml of the 6% dextran solution were
added to known volumes of water and of mixtures of
Ringer's solution, Haemaccel, sodium bicarbonate
and mannitol as used in extracorporeal circulation,
and finally to known volumes actually circulating in
extracorporeal circulation (tab. 3). Volumes were cal-
culated according to the equation:
(V = volume, Q = dose, C = concentration); the
mean was 99.3 ± 2.1% (SD). The great deviation in
one of the extracorporeal circulation volumes (No. 7:
— 5.1%) might be due to insufficient mixing.
Tab. 3. Volume measurements
Volumes measured in ml by adding 40 ml of dextran
6% and determining dextran concentration. ECC =











































The method of determination of dextraü concentra-
tion presented here has the advantage of improved
specificity. Heparin does not interfere, as it does in
the turbidimetric method described by Jacobsson (7),
and there is no significant interference by hexitols
such as mannitol and sorbitol in clinically applied
concentrations, which are known to interfere in the
anthrone method (5, 6). The enzymes in the GÖD-
PAP reagent remain active in spite of the high acidity
involved. Furthermore, this method is much easier to
apply, because no special precautions are necessary,
such as extremely dust free reagents, precise temper^
ature and time control, or unusual laboratory equip-
ment, and it may in part even be performed auto-
matically. It does not involve radioactivity, unlike the
use of tagged albumin or fed blood cells, and in
contrast with dye methods it may be applied repeat-
edly in plasma volume measurements. Disadvantages
are the amount of time involved, which makes this
method unsuitable for emergency volume assessment,
and some risk of allergic reactions (14—16). This risk
may be reduced by application of a dextran prepa-
ration with a mean relative molecular mass of 1000.
However, this has a different disappearance rate,
which will strongly affect the measurements. Separa-
tion of light and heavy dextran fractions might be a
solution to this problem. Accuracy appears to be
sufficient for volumes of the magnitude involved in
plasma volume measurement. It was shown that other
enzymatic glucose methods (hexokinase, oxygen con-
sumption of glucose oxidase) may be used in place of
the GOD-PAP reagent.
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